Mecanismos de control neural cardíaco en la Enfermedad de Chagas. Implicaciones terapéuticas

dc.contributor.authorF S Diego Dávila
dc.contributor.authorJosé H. Donis Hernández
dc.contributor.authorM Argenis Torres
dc.contributor.authorMaría Navas
dc.contributor.authorGabriela Arata de Bellabarba
dc.contributor.authorCarlos J. Vásquez
dc.contributor.authorR. Rossell
dc.contributor.authorCarlos F. Gottberg
dc.contributor.authorSardi Galeno
dc.contributor.authorWilliam Madariaga
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T16:45:16Z
dc.date.available2026-03-22T16:45:16Z
dc.date.issued1992
dc.descriptionCitaciones: 1
dc.description.abstractAccording to the Neurogenic Theory the progressive dilatation of the cardiac chambers, of chagasic patients, is due to a destruction of the cardiac vagal neurons. However, the results of our investigations indicate that the cardiac parasympathetic abnormalities, described in chronic Chagas' heart disease, are compensatory mechanisms secondary to the progressive ventricular dilatation. Cardiac parasympathetic abnormalities, and a reciprocal sympathetic hyperactivity, are also present in non-chagasic cardiac patients. Modern medical treatment, with sympatholytic drugs, prolongs life and prerevents ventricular dilatation in' these non-chagasic cardiac patients. In Chagas' heart disease the pathophysiology of the cardiac sympathetic system, as well as its therapeutic implications, is unknown.
dc.identifier.urihttp://erevistas.saber.ula.ve/index.php/medula/article/view/5541
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/60108
dc.language.isoes
dc.relation.ispartofMedULA: revista de la Facultad de Medicina
dc.sourceUniversidad de Los Andes
dc.subjectMedicine
dc.subjectChagas disease
dc.subjectCardiology
dc.subjectInternal medicine
dc.subjectHeart disease
dc.subjectHeart failure
dc.titleMecanismos de control neural cardíaco en la Enfermedad de Chagas. Implicaciones terapéuticas
dc.typearticle

Files